JNCI Journal of the National Cancer Institute · 1972 · 17 citations · 0 references
Life SciencesImmunologyOncologyCancer ImmunologyImmunoregulationMolecular VirologyAntibody FunctionAntibody-mediated ProtectionAntiviral ImmunityOncogenic VirusesViral InfectionsViral PathogenesisAntibody-dependent Cell-mediated CytotoxicityAntibody-mediated Viral NeutralizationAntibody-mediated Virus NeutralizationAntiviral Humoral ResponseDormant StagesHumoral ImmunosuppressionNeutralizing Antibody ResponsesViral Immune Modulation
Statolon suppressed established Friend virus (FV) leukemia in DBA/2 mice by stimulating an immune response to FV and FV-transformed cells. Mice in which the FV infection was completely suppressed by statolon (FV carriers) produced more FV-neutralizing, FV-cell-binding, in vitro FV-cytotoxic, and in vivo anti-FV-leukemic antibody than mice which rapidly developed leukemia despite treatment with statolon. As FV-carrier mice aged, antibody levels declined and FV emerged from its dormant state to produce overt leukemia.